Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-2 of 2

Sort by

Sort Order Select

Journal Articles

Odronextamab plus chemotherapy in patients with previously untreated diffuse large B-cell lymphoma (DLBCL): First Results from part 1 of the Phase 3 Olympia-3 study

Jean-Marie Michot, Munci Yagci, Katherine Kargus, Hesham Mohamed, Jingxiao Chen, Jurriaan Brouwer-Visser, Aafia Chaudhry, Nazia Iqbal, Matthew Matasar

Blood (2025) 146 (Supplement 1): 65.

https://doi.org/10.1182/blood-2025-65

Published: 2025

Journal Articles

Trial in Progress: Phase 1 Trial Evaluating the Safety and Tolerability of Odronextamab in Combination with Cemiplimab in Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma

Cecilia Carpio, Manjusha Namuduri, Nazia Iqbal, Dishan Liu, Nickolas Sophos, Min Zhu, Ayesha Sabir, Jurriaan Brouwer-Visser, Aafia Chaudhry, Hesham Mohamed, Alejandro Martín García-Sancho

Blood (2023) 142 (Supplement 1): 3100.

https://doi.org/10.1182/blood-2023-179964

Published: 2023